19.23
-0.04 (-0.21%)
| Penutupan Terdahulu | 19.27 |
| Buka | 19.29 |
| Jumlah Dagangan | 1,183,851 |
| Purata Dagangan (3B) | 1,151,046 |
| Modal Pasaran | 1,491,901,824 |
| Harga / Pendapatan (P/E TTM) | 66.31 |
| Harga / Pendapatan (P/E Ke hadapan) | 7.73 |
| Harga / Jualan (P/S) | 0.960 |
| Harga / Buku (P/B) | 0.970 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 23 Oct 2024 - 28 Oct 2024 |
| Margin Keuntungan | 1.51% |
| Margin Operasi (TTM) | 11.28% |
| EPS Cair (TTM) | 0.290 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 9.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 131.10% |
| Nisbah Semasa (MRQ) | 3.39 |
| Aliran Tunai Operasi (OCF TTM) | 141.68 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 112.64 M |
| Pulangan Atas Aset (ROA TTM) | 3.51% |
| Pulangan Atas Ekuiti (ROE TTM) | 1.47% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Bercampur |
| Medical Devices (Global) | Bercampur | Bercampur | |
| Stok | Integra LifeSciences Holdings C | Menurun | Menurun |
AISkor Stockmoo
| Konsensus Penganalisis | -1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | -1.5 |
| Osilator Teknikal | 2.0 |
| Purata | -0.13 |
|
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 3.19% |
| % Dimiliki oleh Institusi | 94.36% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 22.00 (Citigroup, 14.41%) | Jual |
| Median | 21.00 (9.20%) | |
| Rendah | 18.00 (B of A Securities, -6.40%) | Jual |
| Purata | 20.33 (5.72%) | |
| Jumlah | 1 Pegang, 2 Jual | |
| Harga Purata @ Panggilan | 20.52 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Citigroup | 05 Nov 2024 | 22.00 (14.40%) | Jual | 24.91 |
| 01 Oct 2024 | 16.00 (-16.80%) | Jual | 17.50 | |
| Truist Securities | 14 Oct 2024 | 21.00 (9.20%) | Pegang | 19.22 |
| B of A Securities | 07 Oct 2024 | 18.00 (-6.40%) | Jual | 17.43 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 13 Nov 2024 | Pengumuman | Integra’s DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research |
| 04 Nov 2024 | Pengumuman | Integra LifeSciences Reports Third Quarter 2024 Financial Results |
| 04 Nov 2024 | Pengumuman | Integra LifeSciences Announces Appointment of Mojdeh Poul as President and Chief Executive Officer |
| 14 Oct 2024 | Pengumuman | Integra LifeSciences to Host Third Quarter 2024 Financial Results Conference Call on November 4, 2024 |
| 04 Sep 2024 | Pengumuman | Integra LifeSciences to Present at the 2024 Wells Fargo Healthcare Conference |
| 04 Sep 2024 | Pengumuman | Integra LifeSciences to Present at the 22nd Annual Morgan Stanley Healthcare Conference |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2024 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |